XML 48 R18.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2024
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Stockholders’ Equity
Common Stock

The holders of common stock are entitled to receive dividends whenever funds are legally available and when and if declared by the Company’s Board of Directors. We have not historically declared or paid dividends on our common stock.

Stock-Based Compensation Plans

Our 2005 Incentive Plan, as amended, provides for the granting of incentive stock options, non-statutory stock options, restricted stock, stock appreciation rights, performance units and performance shares to employees, non-employee directors and consultants. Shares granted on or after May 16, 2013 as an award of restricted stock, restricted stock units, performance shares or performance units (“full value awards”) are counted against the authorized share reserve as one and nine-tenths (1 9/10) shares for every one (1) share subject to the award, and any shares canceled that were counted as one and nine-tenths shares against the plan reserve will be returned at the same ratio. 

As of December 31, 2024, the 2005 Incentive Plan, as amended, has a total reserve of 32,168,895 shares for issuance of which 3,530,580 shares are available for issuance. We issue new shares from our pool of authorized but unissued shares to satisfy the exercise and vesting obligations of our stock-based compensation plans.

Summary of Stock-Based Compensation Expense

Stock-based compensation related to our stock-based awards and employee stock purchase plan for the year ended December 31, 2024, 2023 and 2022 is as follows (in thousands):
 Year Ended December 31,
 202420232022
Cost of net revenues$6,995 $7,462 $6,438 
Selling, general and administrative123,979 115,992 103,134 
Research and development42,729 30,572 23,795 
Total stock-based compensation$173,703 $154,026 $133,367 

The income tax benefit related to stock-based compensation was $19.0 million, $17.1 million and $14.9 million for the year ended December 31, 2024, 2023 and 2022, respectively.

Restricted Stock Units (“RSUs”)

The fair value of RSUs is based on our closing stock price on the date of grant. RSUs granted generally vest over a period of four years. A summary for the year ended December 31, 2024 is as follows:
Number of Shares
Underlying RSUs
(in thousands)		Weighted Average Grant Date Fair ValueWeighted Average
Remaining
Contractual Term
(in years)		Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
736 $367.63 
Granted657 307.12 
Vested and released(256)370.36 
Forfeited(118)340.47 
Unvested as of December 31, 2024
1,019 $331.10 1.4$212,468 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (calculated by multiplying our closing stock price on the last trading day of fiscal year 2024 by the number of unvested RSUs) that would have been received by the unit holders had all RSUs vested and been released on the last trading day of fiscal year 2024. This amount will fluctuate based on the fair market value of our stock. During 2024, of the 255,643 shares vested and released, 77,212 shares were withheld for employee statutory tax obligations, resulting in a net issuance of 178,431 shares.

The total fair value of RSUs vested as of their respective vesting dates during 2024, 2023 and 2022 was $78.8 million, $63.0 million and $93.7 million, respectively. The weighted average grant date fair value of RSUs granted during 2024, 2023 and 2022 was $307.12, $316.16 and $469.12, respectively. As of December 31, 2024, we expect to recognize $216.0 million of total unamortized compensation costs, net of estimated forfeitures, related to RSUs over a weighted average period of 2.5 years.

Market Based Restricted Stock Units (“MSUs”)

We grant MSUs to members of senior management. Each MSU represents the right to one share of our common stock. The actual number of MSUs which will be eligible to vest will be based on the performance of our stock price relative to the performance of a stock market index over the vesting period. MSUs vest over a period of three years and the maximum number eligible to vest in the future is 250% of the MSUs initially granted.

The following table summarizes MSU activity for the year ended December 31, 2024:
Number of Shares
Underlying MSUs
(in thousands)		Weighted Average Grant Date Fair ValueWeighted Average
Remaining
Contractual Term
(in years)		Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
158 $811.06 
Granted83 617.79 
Vested and released (32)1,102.09 
Forfeited(16)809.22 
Unvested as of December 31, 2024
193 $679.14 1.4$40,272 


The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (calculated by multiplying our closing stock price on the last trading day of 2024 by the number of unvested MSUs) that would have been received by the unit holders had all MSUs been vested and released as of the last trading day of 2024. This amount will fluctuate based on the fair
market value of our stock. During 2024, of the 32,369 shares vested and released, 13,388 shares were withheld for employee statutory tax obligations, resulting in a net issuance of 18,981 shares.

The total fair value of MSUs vested as of their respective vesting dates during 2024, 2023 and 2022 was $10.1 million, $7.8 million and $64.0 million, respectively. As of December 31, 2024, we expect to recognize $51.9 million of total unamortized compensation costs, net of estimated forfeitures, related to MSUs over a weighted average period of 1.4 years.

The fair value of MSUs is estimated at the grant date using a Monte Carlo simulation that includes factors for market conditions. The weighted average assumptions used in the Monte Carlo simulation were as follows: 
 Year Ended December 31,
 202420232022
Expected term (in years)3.03.03.0
Expected volatility52.0 %59.1 %53.8 %
Risk-free interest rate4.3 %4.3 %1.7 %
Expected dividends— — — 
Weighted average fair value per share at grant date$617.79 $629.53 $915.22 
Restricted Stock Units with Performance Conditions (“PSUs”)

Our PSUs typically include a service and performance condition. We recognize share-based compensation expense for PSUs if it is probable that the performance condition will be achieved.

The following table summarizes the PSU performance activity for the year ended December 31, 2024:

Number of Shares
Underlying PSUs
(in thousands)		Weighted Average Grant Date Fair ValueWeighted Average
Remaining
Contractual Term
(in years)		Aggregate
Intrinsic Value
(in thousands)
Unvested as of December 31, 2023
$5 $201.63 
Granted6 206.36 
Vested and released — — 
Forfeited— — 
Unvested as of December 31, 2024
$11 $204.33 1.2$2,299 

As of December 31, 2024, we expect to recognize $1.0 million of total unamortized compensation costs, net of estimated forfeitures, related to PSUs over a weighted average period of 1.2 years.
Employee Stock Purchase Plan (“ESPP”)

In May 2010, our stockholders approved the 2010 Employee Stock Purchase Plan (the “2010 Purchase Plan”) which consists of consecutive overlapping twenty-four month offering periods with four six-month purchase periods in each offering period. Employees purchase shares at 85% of the lower of the fair market value of the common stock at either the beginning of the offering period (grant date) or the end of the purchase period. The 2010 Purchase Plan will continue until terminated by either the Board of Directors or its administrator. The 2010 Purchase Plan also allows for purchase rights to employees outside the U.S. and Canada with six-month offering periods and purchase periods. In May 2021, the 2010 Purchase Plan was amended and restated to increase the maximum number of shares available for purchase to 4,400,000 shares.

The following table summarizes the ESPP shares issued:
Year Ended December 31,
202420232022
Number of shares issued (in thousands)120 114 86 
Weighted average price$213.11 $234.19 $305.24 

As of December 31, 2024, 1,875,920 shares remain available for future issuance.
The fair value of the option component of the 2010 Purchase Plan shares was estimated at the grant date using the Black-Scholes option pricing model with the following weighted average assumptions:
 Year Ended December 31,
  
202420232022
Expected term (in years)1.31.21.5
Expected volatility49.2 %56.4 %50.2 %
Risk-free interest rate4.6 %4.9 %1.8 %
Expected dividends— — — 
Weighted average fair value at grant date$94.75 $132.94 $159.44 

We recognized stock-based compensation related to our employee stock purchase plan of $14.0 million, $20.5 million and $23.5 million for the year ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, we expect to recognize $11.5 million of total unamortized compensation costs related to future employee stock purchases over a weighted average period of 0.7 years.